NASDAQ · Healthcare · Biotechnology
Corbus Pharmaceuticals Holdings, Inc.
CRBP
Corbus Pharmaceuticals Holdings, Inc. CEO Yuval Cohen · Market cap $109.6M.
$8.74
+0.49 · +5.94%
52w hi $20.5652w lo $6.72
Off 52w high 64.1%
55
ROUTINE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $38.50
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 03 | Nishant C Saxena | Chief Business Officer | Buy | 9,000 | $7.58 | +$68K | 55 |
| Jun 02 | Nishant C Saxena | Chief Business Officer | Buy | 4,500 | $7.33 | +$33K | 36 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun